YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Implementation and Dissemination of an Evidence-Based Tobacco Product Use Prevention Videogame Intervention With Adolescents

Not Applicable

Completed

Conditions: Smoking Cessation
Smoking

Interventions: Device: smokeSCREEN web-based game

First Posted Date: 2019-01-24

Last Posted Date: 2022-04-22

Lead Sponsor: Yale University

Target Recruit Count: 560

Registration Number: NCT03815591

Locations: 🇺🇸
play2PREVENT Lab at the Yale Center for Health & Learning Games, New Haven, Connecticut, United States

Creation of a Digital Heart Failure Registry Using a Novel Mobile Health Platform: HUGO-HF

Completed

Conditions: Heart Failure

First Posted Date: 2019-01-22

Last Posted Date: 2020-08-04

Lead Sponsor: Yale University

Target Recruit Count: 85

Registration Number: NCT03810638

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Effects of Psilocybin in Concussion Headache

Phase 1

Terminated

Conditions: Post-Traumatic Headache

Interventions: Drug: Low Dose Psilocybin
Drug: Placebo oral capsule
Drug: High Dose Psilocybin

First Posted Date: 2019-01-16

Last Posted Date: 2023-10-12

Lead Sponsor: Yale University

Target Recruit Count: 12

Registration Number: NCT03806985

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Zero Sodium Peritoneal Dialysate Protocol Pilot Study

Early Phase 1

Completed

Conditions: Potential Applications for Heart Failure
Volume Overload

Interventions: Drug: Two-hour dwell with 10% dextrose in sterile water
Drug: Two-hour dwell with Dianeal Low-Calcium with 4.25% Dextrose

First Posted Date: 2019-01-11

Last Posted Date: 2019-12-18

Lead Sponsor: Yale University

Target Recruit Count: 12

Registration Number: NCT03801226

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Neuroimmune Effects of Opioid Administration

Phase 1

Completed

Conditions: Drug Effect

Interventions: Drug: High Morphine Dose
Drug: Low Morphine Dose

First Posted Date: 2019-01-11

Last Posted Date: 2021-04-27

Lead Sponsor: Yale University

Target Recruit Count: 10

Registration Number: NCT03801629

Locations: 🇺🇸
Cosgrove Lab, New Haven, Connecticut, United States

Peer Online Motivational Interviewing for Sexual and Gender Minority Male Survivors

Not Applicable

Completed

Conditions: Sexual Abuse

Interventions: Behavioral: Motivational Interviewing
Behavioral: Trauma-informed SGM affirmative care

First Posted Date: 2019-01-07

Last Posted Date: 2024-04-22

Lead Sponsor: Yale University

Target Recruit Count: 356

Registration Number: NCT03794986

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

The EXPLORE MG Registry for Myasthenia Gravis

Recruiting

Conditions: Myasthenia Gravis

Interventions: Other: Blood Sample Draw

First Posted Date: 2019-01-03

Last Posted Date: 2024-10-22

Lead Sponsor: Yale University

Target Recruit Count: 800

Registration Number: NCT03792659

Locations: 🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States

Cognitive-Behavioral and Physical Activity Interventions for Binge Eating and Overweight

Not Applicable

Terminated

Conditions: Binge Eating
Overweight and Obesity
Binge-Eating Disorder

Interventions: Behavioral: Cognitive-Behavioral Therapy

First Posted Date: 2018-12-17

Last Posted Date: 2019-10-10

Lead Sponsor: Yale University

Target Recruit Count: 4

Registration Number: NCT03777189

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

The Impact of Phosphate Metabolism on Healthy Aging

Early Phase 1

Suspended

Conditions: XLH
HHRH
Rickets
Hypercalciuria
Hypophosphatemia

Interventions: Drug: phosphate

First Posted Date: 2018-12-10

Last Posted Date: 2024-02-15

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT03771105

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders

Phase 2

Recruiting

Conditions: Alcohol Use

Interventions: Drug: Guanfacine ER
Other: Placebo

First Posted Date: 2018-12-04

Last Posted Date: 2024-08-13

Lead Sponsor: Yale University

Target Recruit Count: 160

Registration Number: NCT03764098

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy